Scarica l'app Stockscreener
3.41
8.09%
-0.30
Dopo l'orario di chiusura:
3.49
0.08
+2.35%
Precedente Chiudi:
$3.71
Aprire:
$3.7
Volume 24 ore:
652.04K
Relative Volume:
0.62
Capitalizzazione di mercato:
$433.83M
Reddito:
$193.01M
Utile/perdita netta:
$-12.15M
Rapporto P/E:
-37.89
EPS:
-0.09
Flusso di cassa netto:
$454.00K
1 W Prestazione:
-13.01%
1M Prestazione:
-17.83%
6M Prestazione:
-19.19%
1 anno Prestazione:
-34.55%
Intervallo 1D:
$3.395
$3.72
Intervallo di 1 settimana:
$3.395
$4.12
Portata 52W:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Confronta CTKB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
3.41 | 472.00M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
133.89 | 236.51B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
98.06 | 144.75B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
371.22 | 142.80B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.74 | 121.80B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.66 | 43.78B | 5.69B | 1.41B | 577.90M | 6.95 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-09 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-31 | Downgrade | Goldman | Buy → Sell |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Is Cytek Biosciences Inc. stock ready for a breakout2025 Momentum Check & High Accuracy Investment Signals - newser.com
14,069 Shares in Cytek Biosciences, Inc. $CTKB Bought by Pallas Capital Advisors LLC - Defense World
Long term hold vs stop loss in Cytek Biosciences Inc.Chart Signals & Fast Exit and Entry Trade Guides - newser.com
Using data filters to optimize entry into Cytek Biosciences Inc.July 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
Will Cytek Biosciences Inc. see short term momentumWeekly Investment Report & Reliable Entry Point Alerts - newser.com
Full technical analysis of Cytek Biosciences Inc. stock2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
Should you wait for a breakout in Cytek Biosciences Inc.Insider Selling & Precise Buy Zone Tips - newser.com
Goldman Sachs Group Inc. Reduces Holdings in Cytek Biosciences, Inc. $CTKB - MarketBeat
Leading vs lagging indicators on Cytek Biosciences Inc. performanceIndex Update & AI Enhanced Trading Alerts - newser.com
Aug Chart Watch: What’s next for Pacific Biosciences of California Inc. stockWeekly Investment Summary & Stepwise Trade Signal Guides - خودرو بانک
Trend analysis for Cytek Biosciences Inc. this weekWeekly Trend Summary & Safe Entry Point Alerts - newser.com
Death Cross: Is Cytek Biosciences Inc stock showing strong momentumJuly 2025 Reactions & Free Risk Controlled Daily Trade Plans - خودرو بانک
How to integrate Cytek Biosciences Inc. into portfolio analysis toolsJuly 2025 PostEarnings & AI Based Buy/Sell Signal Reports - newser.com
Volatility clustering patterns for Cytek Biosciences Inc.CEO Change & Precise Entry and Exit Recommendations - newser.com
Will Cytek Biosciences Inc. bounce back from current supportGold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
Published on: 2025-09-18 21:54:33 - newser.com
Analyzing Cytek Biosciences Inc. with risk reward ratio chartsExit Point & Weekly Watchlist for Hot Stocks - newser.com
Caxton Associates LLP Takes $409,000 Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q’s Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control - NewsBreak: Local News & Alerts
Goldman Sachs Group Inc. Sells 183,751 Shares of Cytek Biosciences, Inc. $CTKB - Defense World
Published on: 2025-09-17 01:47:05 - newser.com
Earnings Miss: Is Cytek Biosciences Inc stock showing strong momentumQuarterly Risk Review & Consistent Profit Focused Trading Strategies - خودرو بانک
Market Recap: Is Cytek Biosciences Inc in a long term uptrendTrade Performance Summary & Free Real-Time Volume Trigger Notifications - خودرو بانک
Jacobs Levy Equity Management Inc. Makes New $2.84 Million Investment in Cytek Biosciences, Inc. $CTKB - MarketBeat
Applying chart zones and confluence areas to Cytek Biosciences Inc.July 2025 Pullbacks & Free Safe Capital Growth Stock Tips - newser.com
Aug Drivers: Is Cytek Biosciences Inc stock a good pick for beginnersJuly 2025 Closing Moves & Daily Oversold Stock Bounce Ideas - خودرو بانک
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.25%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):